Abstract
Downregulation of hSSB1, a single-stranded DNA-binding protein, causes increased radiosensitivity, defective checkpoint activation and genomic instability. However, the mechanisms of hSSB1 function in these responses remain to be uncovered. Here, we present evidence that hSSB1 directly binds p21 and this interaction may prevent p21 from ubiquitin-mediated degradation. Furthermore, both promotion of the G1/S transition and abrogation of the G2/M checkpoints induced by hSSB1 knockdown are partially dependent on p21. Most importantly, hSSB1 and p21 levels are positively correlated in human hepatocellular carcinomas (HCC), as determined by immunostaining. Therefore, hSSB1 may positively modulate p21 to regulate cell cycle progression and DNA damage response, implicating hSSB1 as a novel, promising therapeutic target for cancers such as HCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abbas T, Dutta A . (2009). p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400–414.
Blagosklonny MV, Wu GS, Omura S, el-Deiry WS . (1996). Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochem Biophys Res Commun 227: 564–569.
Brustmann H . (2005). Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study. Gynecol Oncol 98: 396–402.
Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497–1501.
Chen MS, Ryan CE, Piwnica-Worms H . (2003). Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol 23: 7488–7497.
Child ES, Mann DJ . (2006). The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability. Cell Cycle 5: 1313–1319.
Dotto GP . (2000). p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 1471: M43–M56.
Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW et al. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013–1023.
el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J et al. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169–1174.
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
Ferguson AM, White LS, Donovan PJ, Piwnica-Worms H . (2005). Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol Cell Biol 25: 2853–2860.
Fukuchi K, Maruyama H, Takagi Y, Gomi K . (1999). Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells. Biochim Biophys Acta 1451: 206–210.
Gartel AL . (2006). Is p21 an oncogene? Mol Cancer Ther 5: 1385–1386.
Gartel AL, Tyner AL . (2002). The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639–649.
Huang J, Gong Z, Ghosal G, Chen J . (2009). SOSS complexes participate in the maintenance of genomic stability. Mol Cell 35: 384–393.
Inagaki Y, Yasui K, Endo M, Nakajima T, Zen K, Tsuji K et al. (2008). CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma. Cancer Genet Cytogenet 180: 30–36.
Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM et al. (2008). MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167–2174.
Jascur T, Brickner H, Salles-Passador I, Barbier V, El Khissiin A, Smith B et al. (2005). Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein. Mol Cell 17: 237–249.
Jin Y, Lee H, Zeng SX, Dai MS, Lu H . (2003). MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J 22: 6365–6377.
Kang T, Wei Y, Honaker Y, Yamaguchi H, Appella E, Hung MC et al. (2008). GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 13: 36–47.
Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH et al. (2007). P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Liver Int 27: 772–781.
Lee S, Helfman DM . (2004). Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 279: 1885–1891.
Lee YH, Oh BK, Yoo JE, Yoon SM, Choi J, Kim KS et al. (2009). Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis. Mod Pathol 22: 1121–1131.
Li R, Waga S, Hannon GJ, Beach D, Stillman B . (1994). Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534–537.
Li XS, Rishi AK, Shao ZM, Dawson MI, Jong L, Shroot B et al. (1996). Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells. Cancer Res 56: 5055–5062.
Li Y, Bolderson E, Kumar R, Muniandy PA, Xue Y, Richard DJ et al. (2009). HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage response. J Biol Chem 284: 23525–23531.
Liu S, Bishop WR, Liu M . (2003). Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat 6: 183–195.
Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K et al. (1995). p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9: 935–944.
Maki CG, Howley PM . (1997). Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol 17: 355–363.
Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D . (1994). Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391–3395.
Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH . (2004). Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells. Cancer Res 64: 4155–4161.
Moustakas A, Kardassis D . (1998). Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 95: 6733–6738.
O'Reilly MA . (2005). Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death. Antioxid Redox Signal 7: 108–118.
Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A et al. (1995). p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024–1027.
Qin LF, Ng IO, Fan ST, Ng M . (1998). p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int J Cancer 79: 424–428.
Richard DJ, Bolderson E, Cubeddu L, Wadsworth RI, Savage K, Sharma GG et al. (2008). Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature 453: 677–681.
Schoniger-Hekele M, Hanel S, Wrba F, Muller C . (2005). Hepatocellular carcinoma--survival and clinical characteristics in relation to various histologic molecular markers in Western patients. Liver Int 25: 62–69.
Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA . (1994). Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407–3415.
Sherr CJ, Roberts JM . (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501–1512.
Shiohara M, Akashi M, Gombart AF, Yang R, Koeffler HP . (1996). Tumor necrosis factor alpha: posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells. J Cell Physiol 166: 568–576.
Shiraki K, Wagayama H . (2006). Cytoplasmic p21(WAF1/CIP1) expression in human hepatocellular carcinomas. Liver Int 26: 1018–1019.
Skaar JR, Richard DJ, Saraf A, Toschi A, Bolderson E, Florens L et al. (2009). INTS3 controls the hSSB1-mediated DNA damage response. J Cell Biol 187: 25–32.
Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H, Tohyama M . (2002). Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J Cell Biol 158: 321–329.
Touitou R, Richardson J, Bose S, Nakanishi M, Rivett J, Allday MJ . (2001). A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J 20: 2367–2375.
Xiao J, Zhang Z, Chen GG, Zhang M, Ding Y, Fu J et al. (2009). Nucleophosmin/B23 interacts with p21WAF1/CIP1 and contributes to its stability. Cell Cycle 8: 889–895.
Xu SB, Liu XH, Li BH, Zhang Y, Yuan J, Yuan Q et al. (2009). DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells. J Cancer Res Clin Oncol 135: 1791–1798.
Zhang F, Wu J, Yu X . (2009). Integrator3, a partner of single-stranded DNA-binding protein 1, participates in the DNA damage response. J Biol Chem 284: 30408–30415.
Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC . (2001). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: 245–252.
Acknowledgements
We thank the members of the laboratory for their helpful comments on the manuscript. This work was supported by grants from NSFC (30772492 and 30973506 to J-PY, U0732005 to Y-XZ, and 30930045 to TK), from the 863 project (2006AA02A404 to Y-XZ), and from the 973 project (2010CB912201 to TK).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Xu, S., Feng, Z., Zhang, M. et al. hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas. Oncogene 30, 2219–2229 (2011). https://doi.org/10.1038/onc.2010.596
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.596
Keywords
This article is cited by
-
SOSSB1 and SOSSB2 mutually regulate protein stability through competitive binding of SOSSA
Cell Death Discovery (2023)
-
Suppression of TCAB1 expression induced cellular senescence by lessening proteasomal degradation of p21 in cancer cells
Cancer Cell International (2021)
-
The UbL-UBA Ubiquilin4 protein functions as a tumor suppressor in gastric cancer by p53-dependent and p53-independent regulation of p21
Cell Death & Differentiation (2019)
-
RETRACTED ARTICLE: MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance
Journal of Experimental & Clinical Cancer Research (2018)
-
hSSB1 associates with and promotes stability of the BLM helicase
BMC Molecular Biology (2017)